EPISODE · Nov 17, 2022 · 37 MIN
Paolo Antonio Ascierto, MD - Emerging Data on Adjuvant Immunotherapy for Resected Melanoma: What Changes?
from PeerVoice Clinical Pharmacology Video · host PeerVoice
Paolo Antonio Ascierto, MD - Emerging Data on Adjuvant Immunotherapy for Resected Melanoma: What Changes?
Embed this episode
What this episode covers
Visit https://www.peervoice.com/NHW860 to view the entire programme with slides. After completing “Paolo Antonio Ascierto, MD - Emerging Data on Adjuvant Immunotherapy for Resected Melanoma: What Changes?”, participants will be able to: Summarise the latest clinical data on adjuvant immunotherapy for resected melanoma; Describe the strengths and limitations of this evidence within the context of current clinical practice in the adjuvant treatment of resected melanoma; and Identify patients with resected melanoma who are at risk of recurrence.
Ready to play
Paolo Antonio Ascierto, MD - Emerging Data on Adjuvant Immunotherapy for Resected Melanoma: What Changes?
No transcript for this episode yet
Similar Episodes
No similar episodes found.